Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 6309854
Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
expired -
US 6309644
Parasitic nematode transglutaminase proteins and uses thereof
expired -
US 6300101
Methods and compositions including a 13kD B. burgdorferi protein
expired -
US 6300308
Methods and compositions for inducing autoimmunity in the treatment of cancers
expired -
US 6296849
Methods and compositions including a 13kDa B. burgdorferi protein
expired -
US 6294650
Inhibition of mammalian telomerase by peptide nucleic acids
expired -
US 6287607
Potassium calcium citrate compositions and methods therefor
expired -
US 6280958
Rh blood group antigen compositions and methods of use
expired -
US 6277375
Immunoglobulin-like domains with increased half-lives
expired -
US 6271201
Methods for the selective regulation of placental prostanoids and inhibition of labor using IGF-I
expired -
US 6271207
Enhanced expression of transgenes
expired -
US 6265214
Methods and compositions for inducing monocyte cytotoxicity
expired -
US 6262242
Tumor suppressor designated TS10Q23.3
expired -
US 6262257
Calixpyrroles, calixpyridinopyrroles and calixpyridines
expired -
US 6258870
Gels for encapsulation of biological materials
expired -
US 6251871
P16 expression constructs and their application in cancer therapy
expired -
US 6251878
Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotective tamarind oligosaccharides
expired -
US 6248351
Human PEA3 is a tumor suppressor for cancer cells
expired -
US 6242418
Therapeutic uses of BPI protein products for human meningococcemia
expired -
US 6231892
Compositions for coating microcapsules and other surfaces
expired -
US 6210873
Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
expired -
US 6207690
Troglitazone compounds for treating climacteric and cancer
expired -
US 6203793
Compositions and methods for treating thermal injury
expired -
US 6201165
Transgenic animal models for cardiac hypertrophy and methods of use thereof
expired